<DOC>
	<DOCNO>NCT02214680</DOCNO>
	<brief_summary>In study explore combine effect Brimonidine Timolol 0.5 % ( Combigan ) eye drop pupil dilation . It well study phenoma Brimonidine miotic effect pupil , however combined effect alpha agonist beta blocker study .</brief_summary>
	<brief_title>The Effect Topical Treatment With Combigan Compared Timolol Brimonidine Pupil Diameter</brief_title>
	<detailed_description>In study explore combine effect Brimonidine Timolol 0.5 % ( Combigan ) eye drop pupil dilation . It well study phenoma Brimonidine miotic effect pupil , however combined effect alpha agonist beta blocker study . The study subject examine twice , two week apart . On first exam subject receive Combigan eye drop right eye Brimonidine drop leave eye . The effect pupil size 30 minute , 60 minute , 240 minute , 300 minute instillation eyedrop . On second exam subject receive Timolol ( 0.5 % ) eye drop right eye Brimonidine drop leave eye . The effect pupil size 30 minute , 60 minute , 240 minute , 300 minute instillation eyedrop .</detailed_description>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Healthy adult subject ocular pathology Non pregnant woman Normal pupil response Chronic topical treatment Systemic medication affect autonomic nerve system History intraocular surgery Irregular pupil History ocular neurological severe cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pupil diameter</keyword>
	<keyword>Brimonidine</keyword>
	<keyword>Timolol</keyword>
	<keyword>Combigan</keyword>
</DOC>